Search - tctmd.com

Displaying 901 - 920 of 1117

Sort: Relevancy | Date

News Daily News

Un Panel de la FDA Rechaza el Cangrelor para las Indicaciones PCI y Terapia Puente

Yael L. Maxwell

February 13, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

News Daily News

Collateral Flow Associated with Angiographic, Clinical Outcomes in Acute Stroke Patients

Yael L. Maxwell

February 05, 2014

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2013

Yael L. Maxwell

January 27, 2014

News Daily News

Revisión Anual: Los Médicos Debaten las Noticias Intervencionistas Más Importantes de 2013

Yael L. Maxwell

January 27, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

Yael L. Maxwell

January 01, 2014

News Conference News AHA 2013

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

Yael L. Maxwell

November 19, 2013

News Conference News AHA 2013

Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients

Jason Kahn

November 17, 2013

News Conference News AHA 2013

Two Trials Look at Therapeutic Hypothermia in Out-of-Hospital Cardiac Arrest Patients

Yael L. Maxwell

November 16, 2013

News Industry News

Study Examines the Impact of Insulin Treatment Status in Diabetic Patients with Multivessel Coronary Artery Disease

October 31, 2013

News Conference News TCT 2013

FREEDOM: Insulin Status Affects Revascularization Outcomes in Diabetic Patients

October 31, 2013

News Industry News

Study Find Pre-Hospital Administration of Bivalirudin Substantially Improves Outcomes Compared to Heparin in Heart Attack Patients

October 30, 2013

News Conference News TCT 2013

Richard Karl Myler, MD: He Never Met a Stranger

October 30, 2013

News Conference News TCT 2013

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

October 30, 2013

News Conference News TCT 2013

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

October 29, 2013

News Conference News TCT 2013

Intraprocedural ST Predicts Adverse Short-Term Events

October 29, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

News Industry News

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

October 28, 2013

News Industry News

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

October 28, 2013

Advertisement

Un Panel de la FDA Rechaza el Cangrelor para las Indicaciones PCI y Terapia Puente

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Collateral Flow Associated with Angiographic, Clinical Outcomes in Acute Stroke Patients

Year in Review: Physicians Highlight the Most Important Interventional News of 2013

Revisión Anual: Los Médicos Debaten las Noticias Intervencionistas Más Importantes de 2013

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients

Two Trials Look at Therapeutic Hypothermia in Out-of-Hospital Cardiac Arrest Patients

Study Examines the Impact of Insulin Treatment Status in Diabetic Patients with Multivessel Coronary Artery Disease

FREEDOM: Insulin Status Affects Revascularization Outcomes in Diabetic Patients

Study Find Pre-Hospital Administration of Bivalirudin Substantially Improves Outcomes Compared to Heparin in Heart Attack Patients

Richard Karl Myler, MD: He Never Met a Stranger

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

Intraprocedural ST Predicts Adverse Short-Term Events

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content